Chemours Co — Director's Dealing 2023

Feb 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2023-02-10

Reporting Person: Kelliher Susan M. (SVP, People and Health Service)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-10	Common Stock	A	68852	$0.00	Acquired	113489.8412	Direct
2023-02-10	Common Stock	F	28315	$34.35	Disposed	85174.8412	Direct

Footnotes

F1: Vesting of performance share units (PSUs)

F2: Includes directly owned shares, restricted stock units and dividend equivalent units.

F3: Shares automatically withheld to satisfy tax obligations on vesting PSUs. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.